Cautious Outlook Amid Uncertainty: Sell Rating for Oscar Health
TipRanks (Thu, 6-Feb 8:46 AM ET)
Oscar Health Faces Uncertainty Amid Revenue Miss and Enrollment Risks, Analyst Maintains Sell Rating
TipRanks (Thu, 6-Feb 5:41 AM ET)
Oscar Health's Stock Declines Amid Strong Q4 Results Yet Mixed Outlook
Market Chameleon (Wed, 5-Feb 3:41 AM ET)
Oscar Health Announces Fourth Quarter and Full Year 2024 Results; Introduces Full Year 2025 Outlook
Business Wire (Tue, 4-Feb 4:05 PM ET)
Oscar Health, Inc. 2024 Fourth Quarter and Full Year Earnings Conference Call
Business Wire (Thu, 9-Jan 8:00 AM ET)
Oscar Health, Inc. Announces that Mark Bertolini's Foundation Purchases Shares of Oscar Health
Business Wire (Mon, 18-Nov 6:45 AM ET)
Oscar Health Announces New Health Insurance Options in New Jersey in 2025
Business Wire (Fri, 15-Nov 12:15 PM ET)
Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan.
Oscar Health Class A trades on the NYSE stock market under the symbol OSCR.
As of February 11, 2025, OSCR stock price declined to $14.12 with 1,075,669 million shares trading.
OSCR has a beta of 1.02, meaning it tends to be more sensitive to market movements. OSCR has a correlation of 0.03 to the broad based SPY ETF.
OSCR has a market cap of $3.49 billion. This is considered a Mid Cap stock.
Last quarter Oscar Health Class A reported $2 billion in Revenue and -$.62 earnings per share. This fell short of revenue expectation by $-78 million and missed earnings estimates by -$.04.
In the last 3 years, OSCR traded as high as $23.79 and as low as $2.05.
The top ETF exchange traded funds that OSCR belongs to (by Net Assets): VTI, IWM, VB, VXF, VBK.
OSCR has underperformed the market in the last year with a price return of -20.1% while the SPY ETF gained +22.1%. However, in the short term, OSCR had mixed performance relative to the market. It has outperformed in the last 3 months, returning +4.3% vs +1.4% return in SPY. But in the last 2 weeks, OSCR shares have been beat by the market, returning -13.4% compared to an SPY return of +0.9%.
OSCR support price is $14.11 and resistance is $15.33 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OSCR shares will trade within this expected range on the day.